The present technology is generally related to transcatheter heart valves.
A human heart includes four heart valves that determine the pathway of blood flow through the heart: the mitral valve, the tricuspid valve, the aortic valve, and the pulmonary valve. The mitral and tricuspid valves are atrioventricular valves, which are between the atria and the ventricles, while the aortic and pulmonary valves are semilunar valves, which are in the arteries leaving the heart. Ideally, native leaflets of a heart valve move apart from each other when the valve is in an open position, and meet or “coapt” when the valve is in a closed position. Problems that may develop with valves include stenosis in which a valve does not open properly, and/or insufficiency or regurgitation in which a valve does not close properly. Stenosis and insufficiency may occur concomitantly in the same valve. The effects of valvular dysfunction vary, with regurgitation or backflow typically having relatively severe physiological consequences to the patient.
Recently, flexible prosthetic valves supported by stent structures that can be delivered percutaneously using a catheter-based delivery system have been developed for heart and venous valve replacement.
Valve prosthesis 100 can be reduced in diameter, by crimping onto a balloon catheter, and advanced through the venous or arterial vasculature. Once valve prosthesis 100 is positioned at the treatment site, for instance within an incompetent native valve, stent structure 102 may be expanded to hold valve prosthesis 100 firmly in place.
When designing a valve prosthesis such as valve prosthesis 100, valve-frame integration and frame mechanical performance often have competing needs or requirements. For example, when attaching the valve to the frame during valve-frame integration, the valve itself needs to be reinforced to the frame at certain locations without hindering mechanical performance of the frame. Embodiments hereof relate to an improved balloon-expandable transcatheter valve prosthesis configured to minimize tradeoffs between the above-described competing needs.
The techniques of this disclosure generally relate to a valve prosthesis including a one-piece molded valve comprising commissures and reinforcement members applied to the commissures.
In one aspect, the present disclosure provides a valve prosthesis including a one-piece molded valve comprising commissures and commissure cuts in the commissures.
In another aspect, the present disclosure provides a valve prosthesis including a one-piece molded valve. The one-piece molded valve includes commissures and commissure tabs extending radially outward from the commissures. Each commissure tab includes a radially extending body, a first ears attached to the body, and a second ear attached to the body.
In another aspect, the present disclosure provides a method including providing a frustum shaped tube having a folding pattern in a commissure region. The method further includes bringing free edges of valve leaflets together to cause the folding pattern to protrude outward, the folding pattern comprising a first folding line, a second folding line, a third folding line, and a fourth folding line. The second folding line and the third folding line are pulled apart from the first folding line and the fourth folding line to form a commissure tab as a T-shaped protrusion.
In another aspect, the present disclosure provides a valve prosthesis including a one-piece molded valve. The one-piece molded valve includes a commissure and a commissure tab extending radially outward from the commissure. The commissure tab includes a main body, a first ear extending perpendicularly from the main body, and a second ear extending perpendicularly from the main body and in a direction opposite the first ear.
In another aspect, the present disclosure provides a valve prosthesis including a stent structure including a trident post having a Y-shape. The trident post includes a main trunk, a first branch extending distally from the main trunk, and a second branch extending distally from the main trunk.
The details of one or more aspects of the disclosure are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the techniques described in this disclosure will be apparent from the description and drawings, and from the claims.
Specific embodiments are now described with reference to the figures, wherein like reference numbers indicate identical or functionally similar elements. The terms “distal” and “proximal”, when used in the following description to refer to a native vessel, native valve, or a device to be implanted into a native vessel or native valve, such as a heart valve prosthesis, are with reference to the direction of blood flow. Thus, “distal” and “distally”, also referred to as the “outflow” or “outflow direction”, respectively, refer to positions in a downstream direction with respect to the direction of blood flow. The terms “proximal” and “proximally”, also referred to as the “inflow” or “inflow direction”, respectively, refer to positions in an upstream direction with respect to the direction of blood flow.
Although the description is in the context of treatment of an aortic heart valve, embodiments may also be used where it is deemed useful in other valved intraluminal sites that are not in the heart. For example, embodiments may be applied to other heart valves or venous valves as well.
Referring now to
Stent structure 302 of valve prosthesis 300 may be a unitary frame or scaffold that supports prosthetic valve 304 including one or more valve leaflets 310 within the interior of stent structure 302. Prosthetic valve 304 is capable of blocking flow in one direction to regulate flow there-through via valve leaflets 310 that may form a bicuspid or tricuspid replacement valve. Although prosthetic valve 304 is illustrated and discussed herein as having three valve leaflets 310, i.e., prosthetic valve 304 has a tricuspid leaflet configuration, a bicuspid leaflet configuration may be used in other embodiments. More particularly, as valve prosthesis 300 is configured for placement within a native aortic valve which typically has three leaflets, prosthetic valve 304 may include three valve leaflets 310. However, valve prosthesis 300 is not required to have the same number of leaflets as the native valve. If valve prosthesis 300 is alternatively configured for placement within a native valve having two leaflets such as the mitral valve, prosthetic valve 304 may include two or three valve leaflets 310.
Stent structure 302 is balloon-expandable. As such, stent structure 302 is made from a plastically deformable material such that when expanded by a dilatation balloon, stent structure 302 maintains its radially expanded configuration. Stent structure 302 may be formed from stainless steel such as 316L or other suitable metal, such as platinum iridium, cobalt chromium alloys such as MP35N or L605, or various types of polymers or other similar materials, including the materials coated with various surface deposits to improve clinical functionality. Stent structure 302 is configured to be rigid such that it does not deflect or move when subjected to in-vivo forces, or such that deflection or movement is minimized when subjected to in-vivo forces.
Stent structure 302 includes an inflow portion 312 and an outflow portion 314. Stent structure 302 is a tubular component defining a central lumen or passageway 318, and has an inflow end 320 and an outflow end 322. When expanded, a diameter of inflow end 320 of stent structure 302 is substantially the same as a diameter of outflow end 322 of stent structure 302 in one embodiment.
Inflow portion 312 extends distally from inflow end 320 of stent structure 302. Inflow portion 312 includes inflow crowns 324, central crowns 326, outflow crowns 328, inflow struts 330, central struts 332, and outflow struts 334. Inflow portion 312 further includes an inflow crown ring 323 defined by inflow crowns 324, inflow struts 330, and central crowns 326. Inflow portion 312 further includes an outflow crown ring 335 defined by outflow crowns 328, outflow struts 334, and central crowns 326. Inflow portion 312 generally extends between inflow crown ring 323 and outflow crown ring 335.
In between inflow crown ring 323 and outflow crown ring 335, inflow portion cells 336, sometimes called side openings, are formed in rows, and more particularly, in four rows R1, R2, R3, and R4. Each row R1, R2, R3, R4 includes 12 inflow portion cells 336. Inflow portion cells 336 of the proximal most row R1 are defined by inflow crowns 324, inflow struts 330, central crowns 326, and central struts 332. Inflow portion cells 336 of the next most proximal rows R2, R3 are defined by central crowns 326 and central struts 332. Inflow portion cells 336 of the distal most row R4 are defined by outflow crowns 328, outflow struts 334, central crowns 326, and central struts 332. Generally, inflow portion cells 336 are diamond-shaped openings having the same or identical shaped, e.g., are sometimes called symmetric.
Generally, a crown is defined where two struts connect and a node is defined as a region where two crowns connect. Accordingly, inflow crowns 324 are defined where inflow struts 330 connect. Outflow crowns 328 are defined where outflow struts 334 connect. Central crowns 326 are defined where inflow struts 330 connect, where outflow struts 334 connect, and where central struts 332 connect. Central nodes 337 are defined where central crowns 326 connect.
Outflow portion 314 is formed proximate to outflow end 322 of stent structure 302 and between outflow end 322 and inflow portion 312. Outflow portion 314 includes an outflow portion crown ring 338, commissure posts 340, and non-commissure posts 342. Outflow portion 314 can be configured in a shape that forms a central lumen or passageway.
Outflow portion crown ring 338 includes outflow portion struts 346, superior crowns 348, and inferior crowns 350. Each outflow portion struts 346 is connected at one end to an adjacent outflow crown strut 346 at a superior crown 348 and on the opposite end to an adjacent outflow crown strut 346 at an inferior crown 350. Inferior crowns 350 are connected to either a commissure post 340 or a non-commissure post 342. More particularly, every other inferior crown 350 is connected to a commissure post 340 and every other inferior crown 350 is connected to a non-commissure post 342 in an alternating repeating arrangement.
Non-commissure posts 342, sometimes called axial frame members 342, extend longitudinally between and connect inferior crowns 350 of outflow portion crown ring 338 and outflow crowns 328 of inflow portion 312. In accordance with this embodiment, non-commissure posts 342 are shaped as a figure eight and can be used as markers for depth of implant as well as clocking of valve prosthesis 300. As used herein, longitudinally is in a direction parallel with the longitudinal axis, radially is perpendicular and in a radial direction from the longitudinal axis, and circumferentially is in a plane perpendicular to the longitudinal axis and in a direction along the circumference of valve prosthesis 300.
Commissure posts 340 extend longitudinally and include axial frame members 352 and trident posts 354. Axial frame members 352 extend longitudinally between and connect inferior crowns 350 of outflow portion crown ring 338 and outflow crowns 328 of inflow portion 312. Trident posts 354 extend in a cantilever fashion and in the outflow or distal direction from inferior crowns 350 of outflow portion crown ring 338. Trident posts 354 have a central longitudinal slot 384 in this embodiment although are solid linear members in another embodiment. Axial frame members 352 and trident posts 354 are parallel with one another and are segments of commissure posts 340, which are linear members.
Prosthetic valve 304 is a one piece 3D molded structure in accordance with this embodiment. Illustratively, a single cylindrical piece is molded to form prosthetic valve 304. Accordingly, although various structures of prosthetic valve 304 are discussed below, prosthetic valve 304 is integral, i.e., formed from a single piece and not a plurality of separate pieces connected together.
Prosthetic valve 304 may be made of pericardial material; however, may instead be made of another material. Natural tissue for prosthetic valve 304 may be obtained from, for example, heart valves, aortic roots, aortic walls, aortic leaflets, pericardial tissue, such as pericardial patches, bypass grafts, blood vessels, intestinal submucosal tissue, umbilical tissue and the like from humans or animals. Synthetic materials suitable for use as prosthetic valve 304 include DACRON polyester commercially, other cloth materials, nylon blends, polymeric materials, and vacuum deposition nitinol fabricated materials. One polymeric material from which prosthetic valve 304 can be made is an ultra-high molecular weight polyethylene material. With certain materials, it may be desirable to coat one or both sides of prosthetic valve 304 with a material that will prevent or minimize overgrowth. It is further desirable that the material is durable and not subject to stretching, deforming, or fatigue.
Prosthetic valve 304 includes valve leaflets 310 and a valve inflow cylinder 356 proximal of valve leaflets 310. For example, valve inflow cylinder 356 is the remaining un-molded portion of the cylindrical material used to form prosthetic valve 304 and valve leaflets 310 are the molded portion.
Valve leaflets 310 are defined by cusps 358, commissures 360, and free edges 362. Adjoining pairs of valve leaflets 310 are attached to one another at their lateral ends to form commissures 360, with free edges 362 of valve leaflets 310 forming coaptation edges that meet in an area of coaptation 364. The region within cusps 358, commissures 360, and free edges 362 are referred to as a belly 366 of valve leaflets 310.
Valve inflow cylinder 356 has a cylindrical inflow end 368, sometimes called a nadir 368. Valve inflow cylinder 356 extends in the outflow direction from inflow end 368 as a cylinder to cusps 358, which form the outflow end of valve inflow cylinder 356. Valve inflow cylinder 356 joins valve leaflets 310 at cusps 358.
Prosthetic valve 304 is disposed within and secured to at least trident posts 354 of commissure posts 340 of stent structure 302. More particularly, commissures 360 including reinforcement members 502 are attached to trident posts 354, e.g., with commissure stitching 370. In accordance with this embodiment, trident posts 354 includes slots 384 into which commissures 360 and reinforcement members 502 are passed and then stitched using commissure stitching 370.
In addition, prosthetic valve 304 may also be disposed within and secured to inflow portion 312 of stent structure 302. More particularly, a margin of attachment (MOA) 372 of valve inflow cylinder 356, e.g., a region directly adjacent cylindrical inflow end 368, is attached to inflow portion 312, e.g., with MOA stitching 374.
Valve prosthesis 300 further includes a skirt 376, which encloses or lines a portion of stent structure 302. Skirt 376 is not illustrated in
Skirt 376 may enclose or line stent structure 302. Skirt 376 may be a natural or biological material such as pericardium or another membranous tissue such as intestinal submucosa. Alternatively, skirt 376 may be a low-porosity woven fabric, such as polyester, Dacron fabric, or PTFE. In one embodiment, skirt 376 may be a knit or woven polyester, such as a polyester or PTFE knit, which can be utilized when it is desired to provide a medium for tissue ingrowth and the ability for the fabric to stretch to conform to a curved surface. Polyester velour fabrics may alternatively be used, such as when it is desired to provide a medium for tissue ingrowth on one side and a smooth surface on the other side.
In accordance with this embodiment, skirt 376 includes an outflow end outer skirt 378, an inflow end outer skirt 380, and an inner skirt 382. Outflow end outer skirt 378 is located on the outer surface of outflow crowns 328 and outflow struts 334 of inflow portion 312. Inflow end outer skirt 380 is located on the outer surface of inflow crowns 324, inflow struts 330, central crowns 326, and central struts 332. More particularly, inflow end outer skirt 380 covers first row R1 of inflow portion cells 336. Inner skirt 382 is located on the inner surface of inflow portion 312 and extends between inflow crown ring 323 and outflow crown ring 335.
Referring now to
In accordance with this embodiment, reinforcement members 502, sometimes called pledgets or additional material, are rectangular strips of material at commissures 360. Reinforcement members 502 are formed of any of the materials listed above for prosthetic valve 304 including tissue, fabric, or polymer.
Reinforcement members 502 are applied to commissures 360 using any one of a number of attachments, e.g., sutures, collagen bonding, adhesive, or other attachment techniques. In one embodiment, reinforcement members 502 are applied to commissures 360 prior to 3D molding of prosthetic valve 304.
As illustrated in
Delivery of valve prosthesis 300 may be accomplished via a percutaneous transfemoral approach or a transapical approach directly through the apex of the heart via a thoracotomy, or may be positioned within the desired area of the heart via different delivery methods known in the art for accessing heart valves. During delivery, valve prosthesis 300 remains compressed until it reaches a target diseased native heart valve, at which time a balloon of a delivery system is inflated in order to radially expand valve prosthesis 300 in situ. Valve prosthesis 300 is configured to be expanded within the native valve leaflets of the patient's defective valve, to thereby retain the native valve leaflets in a permanently open state. The delivery system is then removed and transcatheter valve prosthesis 300 remains deployed within the native target heart valve.
Prosthetic valve 804 of
Referring now to
Commissure cuts 806 allow commissures 360 to be spread apart for insertion of commissures tabs 902 inside of commissures 360 and commissure cuts 806. Commissure tabs 902 are formed from any of the materials listed above for prosthetic valve 304 including tissue, fabric, or polymer.
In accordance with this embodiment, trident post 1154 is a solid member in contrast to trident posts 354 of
Commissure tabs 902 provide an attachment between commissures 360 and trident posts 1154. By decoupling direct attachment of commissures 360 to trident posts 1154, commissure tabs 902 reduce stress on commissures 360 and trident posts 1154.
In accordance with this embodiment, commissure reinforcement layers 1202 are stitched to commissures 360 and commissure tabs 902 with reinforcement stitching 1206. Tab stitching 1208 further attaches commissures 360 to commissure tabs 902. Reinforcement stitching 1206 passes through commissure reinforcement layers 1202, commissures 360 and commissure tabs 902, whereas tab stitching 1208 passes through commissures 360 and commissure tabs 902.
Although attachment of commissure tabs 902 to trident post 1154 as solid members is illustrated and discussed above in reference to
Tissue coupon 1300 of
Prosthetic valve 1304 of
Referring now to
In commissure regions 1310 between each valve leaflet 310 at distal edge 1306, tissue coupon 1300 has folding pattern 1402 including a first folding line 1, a second folding line 2, a third folding line 3, and a fourth folding line 4. Each folding line 1-4 extends proximally from distal edge 1306. Folding lines 1 and 4 are adjacent valve leaflets 310 and folding lines 2 and 3 are between folding lines 1 and 4.
As illustrated in the top plan view of
As illustrated in
The extra material of tissue coupon 1300 used to form commissure tabs 1404 reduces the length of distal edge 1306 to approximately equal the length of proximal edge 1308. This results in prosthetic valve 1304 having a cylindrical shape of a uniform diameter, or approximately so.
Commissure tabs 1404 provide a radially extending attachment of commissures 360 to trident posts 1154. By decoupling direct attachment of commissures 360 to trident posts 1154, commissure tabs 1404 reduce stress applied to prosthetic valve 1304.
Although attachment of commissure tabs 1404 to trident posts 1154 as solid members is illustrated and discussed above in reference to
Tissue coupon 1700 of
Prosthetic valve 1704 of
Referring now to
Paying particular attention now to
Main body 1708 extends longitudinally and distally along inner surface 1714, radially outward along distal end surface 1716, and longitudinally and proximally along outer surface 1718 of trident post 1754. First ear 1710 and second ear 1712 extend from outer surface 1718 of trident post 1754 radially inward and along side surfaces 1720, 1722 of trident post 1754 and are attached to commissure 360 with tab stitching 1724. In other words, ears 1710, 1712 wrap around side surfaces 1720, 1722 of trident post 1754 to be attached to commissure 360 with tab stitching 1724. In this manner, commissure tabs 1706 wrap around and are attached to trident posts 1754.
Commissure tabs 1706 provide a radially extending attachment to trident posts 1754. By decoupling direct attachment of commissures 360 to trident posts 1754, commissure tabs 1706 reduce stress applied to prosthetic valve 1704.
Although trident post 1754 is a solid rectangular member in accordance with this embodiment, in other embodiments, trident post 1754 can have other shapes. For example, trident post 1754 is a solid cylindrical member in one embodiment and commissure tabs 1706 wrap around and are attached to the solid cylindrical member in a similar manner as that described above.
Referring now to
Commissure tab 2200 includes a first pocket 2110 and a second pocket 2112 into which branches 2104, 2106 are positioned. More particularly, commissure tab 2200 includes a radial extending body 2114, a first ear 2116, and a second ear 2118. First ear 2116 and second ear 2118 extend from body 2114, invert back inwards and wrap around branches 2104, 2106, and are attached to body 2114 with tab stitching 2120. Body 2114 along with ears 2116, 2118 define pockets 2110, 2112, respectively.
To assemble commissure tab 2200 to trident post 2100, in one embodiment, commissure tab 2200 is fabricated as discussed above to have pockets 2110, 2112. Then branches 2104, 2106 of trident post 2100 are inserted into pockets 2110, 2112. By pre-assembling commissure tabs 2200 and having the open design of trident posts 2100, stitching of commissure tabs 2200 to trident post 2100 is avoided and manufacturing is simplified.
Further, by inverting and sewing ears 2116, 2118 to body 2114, commissure tab 2200 is thickened and thus strengthened. In addition, by decoupling direct attachment of commissures 360 to trident posts 2100, commissure tabs 2200 reduce stress applied to the prosthetic valve. Accordingly, commissure tabs 2200 provides a robust connection to commissures 360 while at the same time reduce stress on commissures 360.
It should be understood that various aspects disclosed herein may be combined in different combinations than the combinations specifically presented in the description and accompanying drawings. It should also be understood that, depending on the example, certain acts or events of any of the processes or methods described herein may be performed in a different sequence, may be added, merged, or left out altogether (e.g., all described acts or events may not be necessary to carry out the techniques). In addition, while certain aspects of this disclosure are described as being performed by a single module or unit for purposes of clarity, it should be understood that the techniques of this disclosure may be performed by a combination of units or modules associated with, for example, a medical device.
This application claims the benefit of U.S. Provisional Application No. 63/425,501, filed Nov. 15, 2022, the contents of which are incorporated by reference herein in their entirety.
Number | Date | Country | |
---|---|---|---|
63425501 | Nov 2022 | US |